Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

RLDatix to Acquire Porzio Life Sciences

RLDatix, the leading global provider of healthcare operations software and services that drive safer care, announced that it has entered into a definitive agreement to acquire Porzio Life Sciences, a market leader in compliance solutions for the life sciences industry which had been a wholly-owned subsidiary of the law firm of Porzio, Bromberg & Newman since 2004.

Porzio Life Sciences simplifies compliance by combining its regulatory expertise with product innovation to deliver a truly unique solution to its customers. Designed by experienced lawyers and regulatory experts, Porzio Life Sciences is a database and software solutions business that automates transparency reporting and other compliance tasks for organizations around the world. Combined with RLDatix’s existing governance, risk, compliance (GRC) and workforce management offerings, Porzio Life Sciences broadens the company’s capabilities across life sciences and provides a comprehensive set of tools at global scale.

Recommended AI News: Delinea Reduces Ransomware Risk for Customers Using Azure AD Government, Makes Secure Remote Access More Seamless

“RLDatix’s acquisition of Porzio Life Sciences, when combined with our current solutions, will create a comprehensive suite of compliance offerings for the life sciences industry and a global leader in governance, risk, compliance and workforce management,” said Jeff Surges, CEO, RLDatix. “We’re excited to bring these capabilities together and to forge an innovative new path forward for our hundreds of pharmaceutical, biotech and medical device clients around the world.”

Porzio, Bromberg & Newman will continue to maintain a strategic relationship with the company after the transaction closes. The two entities will co-market Porzio Life Sciences’ products and services and will collaborate to deliver innovative compliance solutions for the life sciences industry.

Related Posts
1 of 33,389

Recommended AI News: Borrego’s Web-Based O&M Customer Portal Provides Real-Time Actionable Insights into Solar Project Operations

“This is a great day for our clients,” said Vito A. Gagliardi, Jr., Managing Principal, Porzio, Bromberg & Newman. “Under RLDatix’s leadership, Porzio Life Sciences will continue to simplify the compliance efforts of pharmaceutical companies while benefiting from the global scale and reach that is critical to driving ongoing success and growth.”

John Oroho, the Porzio, Bromberg & Newman lawyer who founded and developed Porzio Life Sciences, will join RLDatix as President and General Manager of RLDatix’s life sciences division. “The success of Porzio Life Sciences was always predicated on the notion of being built from the law,” said Oroho. “As we join forces with RLDatix, I am inspired by their commitment to putting the voice of the customer at the forefront of everything they do. Together, we will deliver innovative solutions that exceed the expectations of our clients.”

Recommended AI News: Husqvarna Affirms its Commitment to Autonomous Mowing and Leadership in Robotics as a Service (RaaS) with Expanded Investment in Robin Autopilot

[To share your insights with us, please write to]

Comments are closed.